SCHEMBL19805201

SCHEMBL19805201

Clc1nc(Cl)c2sc3nc(N4CCOCC4)ccc3c2n1

nearest known ligand 0.71

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 1/20 0.41
▸ PIK3CA P42336 3/20 0.39
▸ GAA P10253 1/20 0.39
▸ RAB9A P51151 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ MAPT P10636 2/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CNR2 P34972 3/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ PIK3CD O00329 1/20 0.34
▸ PIK3CB P42338 1/20 0.34
▸ PIK3CG P48736 1/20 0.34
▸ AR P10275 1/20 0.34
▸ ADORA2A P29274 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20467154 0.84 ALOX15 (0.40) ALOX15PIK3CAGAARAB9AKMT2A
SCHEMBL19805189 0.84 PIK3CA (0.51) ALOX15PIK3CAGAAKMT2ANPC1
SCHEMBL19805182 0.83 HTR2C (0.44) ALOX15PIK3CAKMT2APIK3CDPIK3CB
SCHEMBL19805202 0.75 MAP4K4 (0.43) PIK3CACNR2SMN1; SMN2PIK3CDPIK3CG
SCHEMBL19805188 0.72 KDM4E (0.49) PIK3CAGAAKMT2AMEN1MAPT
SCHEMBL1164956 0.71 PIK3CA (0.71) ALOX15PIK3CAKMT2AMEN1PIK3CD
SCHEMBL19805166 0.70 GUSB (0.58) PIK3CAKMT2APIK3CDPIK3CBPIK3CG
SCHEMBL19805167 0.70 PIK3CA (0.60) PIK3CAKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL19805163 0.69 TSHR (0.44) PIK3CAKMT2APIK3CDPIK3CBPIK3CG
SCHEMBL19805093 0.68 LIMK1 (0.53) RAB9AKMT2AMEN1NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11339178-B2 Inhibitors of microbial beta-glucuronidase enzymes and uses thereof THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2022-05-24 — — US disclosed
US-20190330237-A1 INHIBITORS OF MICROBIAL BETA-GLUCURONIDASE ENZYMES AND USES THEREOF THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2019-10-31 — — US disclosed
WO-2018017874-A1 INHIBITORS OF MICROBIAL BETA-GLUCURONIDASE ENZYMES AND USES THEREOF THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2018-01-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11339178-B2 Inhibitors of microbial beta-glucuronidase enzymes and uses thereof GUSB, ENGASE, MGAM ALOX15 1595/4885PIK3CA 1949/4885GAA 4/4885
US-20190330237-A1 INHIBITORS OF MICROBIAL BETA-GLUCURONIDASE ENZYMES AND USES THEREOF GUSB, ENGASE, MGAM ALOX15 1595/4885PIK3CA 1949/4885GAA 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback